뉴스벤징가
United Therapeutics Expands Immune Therapy Pipeline With Thymmune
· 발표
기사 요약
United Therapeutics (UTHR) acquires Thymmune Therapeutics for $140M upfront, with up to $160M in milestone-based payments.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
United Therapeutics (UTHR) acquires Thymmune Therapeutics for $140M upfront, with up to $160M in milestone-based payments.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…